ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,650.61
0.34%
US Tech 100
19,761.20
-0.43%
다우존스 지수
40,800.86
1.47%
Bitcoin
64,486.60
-0.56%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) 뉴스

AVDL

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AVDL
일자시간출처헤드라인심볼기업
2021/10/1606:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/10/1606:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Ongoing FDA Review of NDA for FT218 for Patients with NarcolepsyNASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/09/2021:00GlobeNewswire Inc.Avadel Recognizes World Narcolepsy Day and Announces New Data Presentations from Pivotal Phase 3 REST-ON Trial of FT218 at Upcoming ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/09/1805:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/09/0221:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/1621:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Publication of Data from Pivotal Phase 3 REST-ON Trial of FT218 in Adults with Narcolepsy in SLEEPNASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0922:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0921:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0921:00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0608:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0608:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0608:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0608:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0608:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0505:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/08/0221:00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2021 Financial Results on August 9thNASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/07/0721:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Ladenburg Thalmann Annual Healthcare Conference 2021NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/06/0922:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/06/0922:00GlobeNewswire Inc.Avadel Presents New Clinical Data from Pivotal Phase 3 REST-ON Trial Supporting Clinical Benefit of FT218 in Patients with Na...NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/06/0506:12Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/06/0321:00GlobeNewswire Inc.Avadel to Present New Efficacy and Safety Data from Pivotal Phase 3 REST-ON Trial of FT218 at SLEEP 2021NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/06/0221:00GlobeNewswire Inc.Avadel Pharmaceuticals Expands Leadership Team with Three Strategic HiresNASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/05/2521:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Jefferies Virtual Healthcare ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/05/1022:35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/05/1021:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/05/0105:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/03/1006:09Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/03/0422:00GlobeNewswire Inc.Avadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an Exclusive Collaboration on the 2021 ...NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/03/0122:19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVDLAvadel Pharmaceuticals PLC
2021/02/1722:21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AVDLAvadel Pharmaceuticals PLC
 검색 관련기사 보기:NASDAQ:AVDL

최근 히스토리

CCOM
US100
US Tech 100
CCOM
US500
US 500
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
AAPL
Apple
SPI
SP500
S&P 500
FX
USDJPY
US Dollar vs Yen
CCOM
SILVER
SILVER
NYSE
MCD
McDonalds
CCOM
US30
US 30
NYSE
MRK
Merck
USOTC
ADDYY
Adidas (QX)
NYSE
DIS
Walt Disney
COIN
BTCUSD
Bitcoin
NYSE
XOM
Exxon Mobil
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유